WPRIM Management System> DCMS> Kidney Research and Clinical Practice> 2019> 38> 2

Volume: 38 Issue: 2

1. Use of mesenchymal stem cells for chronic kidney disease Page:131—134
2. Is high fluid intake good for the kidney? Page:135—137
3. Blood pressure measurement in patients with chronic kidney disease: from clinical trial to clinical practice Page:138—140
4. Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease Page:141—144
5. New insights into the transcriptional regulation of aquaporin-2 and the treatment of X-linked hereditary nephrogenic diabetes insipidus Page:145—158
6. Online hemodiafiltration and mortality risk in end-stage renal disease patients: A critical appraisal of current evidence Page:159—168
7. Analysis of mortality risk from Korean hemodialysis registry data 2017 Page:169—175
8. Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility Page:176—185
9. Renal tubular P-glycoprotein expression is reduced in plasma cell disorders Page:186—195
10. Sub-morbid dehydration-associated glomerular hyperfiltration: An emerging reality? Page:196—204
11. Serum alkaline phosphatase and γ-glutamyl transferase in acute pyelonephritis Page:205—211
12. Comparisons between different blood pressure measurement techniques in patients with chronic kidney disease Page:212—219
13. Fracture risk in chronic kidney disease: A Korean population-based cohort study Page:220—228
14. Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism Page:229—238
15. Impact of body mass index on survival in patients undergoing peritoneal dialysis: Analysis of data from the Insan Memorial End-Stage Renal Disease Registry of Korea (1985–2014) Page:239—249
16. Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease Page:250—252
17. Hemolytic uremic syndrome caused by Escherichia fergusonii infection Page:253—255